A Multiple-Dose Pharmacokinetics Study of Three Gefapixant (AF-219/MK-7264) Formulations
Clinical trial NCT02790840 · COMPLETED
Trial details
- NCT number
- NCT02790840
- Sponsor
- Afferent Pharmaceuticals, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-16
- Primary completion
- 2016-06-15
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.